Compare RNXT & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNXT | MBBC |
|---|---|---|
| Founded | 2012 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4M | 33.5M |
| IPO Year | 2021 | N/A |
| Metric | RNXT | MBBC |
|---|---|---|
| Price | $0.96 | $13.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 256.3K | 2.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.60 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,000.00 | N/A |
| Revenue This Year | $2,995.35 | N/A |
| Revenue Next Year | $219.61 | N/A |
| P/E Ratio | ★ N/A | $47.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.70 | $9.94 |
| 52 Week High | $1.45 | $14.64 |
| Indicator | RNXT | MBBC |
|---|---|---|
| Relative Strength Index (RSI) | 57.24 | 50.35 |
| Support Level | $0.78 | $12.85 |
| Resistance Level | $1.07 | $13.75 |
| Average True Range (ATR) | 0.07 | 0.34 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 67.89 | 35.36 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.